Table 2.

Proportion of responders and nonresponders to donepezil stratified by APOE-ε4 and rs1080985 genotypes, respectively

Responders (n = 142)
(4) APOE-ε4 (–)	(3) APOE-ε4 (–)	(2) APOE-ε4 (+)	(1) APOE-ε4 (+)
rs1080985 G-allele (–)	rs1080985 G-allele (+)	rs1080985 G-allele (-)	rs1080985 G-allele (+)
59 (41.4%)	20 (14.1%)	50 (35.2%)	12 (8.5%)
Nonresponders (n = 64)
APOE-ε4 (–)	APOE-ε4 (–)	APOE-ε4 (+)	APOE-ε4 (+)
rs1080985 G-allele (–)	rs1080985 G-allele (+)	rs1080985 G-allele (–)	rs1080985 G-allele (+)
25 (38.7%)	12 (18.8%)	18 (28.1%)	8 (12.5%)
OR (95% CI)
Reference	1.450 (0.430–4.888); p = 0.548	0.87 (0.315–2.404); p = 0.788	1.611 (0.384–6.752); p = 0.705